74 related articles for article (PubMed ID: 33448877)
1. The effect of factor V Leiden carriage on maternal and fetal health.
Bloomenthal D; von Dadelszen P; Liston R; Magee L; Tsang P
CMAJ; 2002 Jul; 167(1):48-54. PubMed ID: 12137081
[TBL] [Abstract][Full Text] [Related]
2. Factor V leiden and ischemic stroke risk: the Genetics of Early Onset Stroke (GEOS) study.
Hamedani AG; Cole JW; Cheng Y; Sparks MJ; O'Connell JR; Stine OC; Wozniak MA; Stern BJ; Mitchell BD; Kittner SJ
J Stroke Cerebrovasc Dis; 2013 May; 22(4):419-23. PubMed ID: 22100829
[TBL] [Abstract][Full Text] [Related]
3. Survival advantage of heterozygous factor V Leiden carriers in murine sepsis.
Kerschen E; Hernandez I; Zogg M; Maas M; Weiler H
J Thromb Haemost; 2015 Jun; 13(6):1073-80. PubMed ID: 25690763
[TBL] [Abstract][Full Text] [Related]
4. High prevalence of protein C, protein S, antithrombin deficiency, and Factor V Leiden mutation as a cause of hereditary thrombophilia in patients of venous thromboembolism and cerebrovascular accident.
Ali N; Ayyub M; Khan SA
Pak J Med Sci; 2014; 30(6):1323-6. PubMed ID: 25674132
[TBL] [Abstract][Full Text] [Related]
5. Association between Factor-V Leiden and occurrence of acute myocardial infarction using a large NIS database.
Zuniga L; Davis M; Movahed MR; Hashemzadeh M; Hashemzadeh M
Am J Blood Res; 2023; 13(6):207-212. PubMed ID: 38223312
[TBL] [Abstract][Full Text] [Related]
6. A genetic association study of D-dimer levels with 50K SNPs from a candidate gene chip in four ethnic groups.
Weng LC; Tang W; Rich SS; Smith NL; Redline S; O'Donnell CJ; Basu S; Reiner AP; Delaney JA; Tracy RP; Palmer CD; Young T; Yang Q; Folsom AR; Cushman M
Thromb Res; 2014 Aug; 134(2):462-7. PubMed ID: 24908450
[TBL] [Abstract][Full Text] [Related]
7. Lower Limb Deep Venous Thrombosis After Posterior Spinal Fusion as an Initial Manifestation of Factor V Leiden Mutation in a Pediatric Patient: A Case Report.
Cortes-Nieves CJ; Ramirez N; Nieves A; RamÃrez N
Cureus; 2024 Apr; 16(4):e57543. PubMed ID: 38707128
[TBL] [Abstract][Full Text] [Related]
8. Comparison of an Unlabeled Probe High-Resolution Melting Analysis Assay (HRMA) for Factor V Leiden 1691 G/A Mutation to a Fluorogenic 5' Nuclease PCR Hydrolysis Assay.
Han H; Lewis S
J Appl Lab Med; 2024 May; ():. PubMed ID: 38775465
[TBL] [Abstract][Full Text] [Related]
9. Budd Chiari Syndrome with Portal Vein Thrombosis Managed Successfully with Direct Intrahepatic Portosystemic Shunt: A Case Report and Review of the Literature.
Malakar S; Mathur A; Agarwal A; Mishra P; Shirol VV; Yadav RR; Ghoshal UC
J Clin Exp Hepatol; 2023; 13(5):917-920. PubMed ID: 37693264
[TBL] [Abstract][Full Text] [Related]
10. Clinical impact of the PAI-1 4G/5G polymorphism in Chinese patients with venous thromboembolism.
Wang Z; Kong L; Luo G; Zhang H; Sun F; Liang W; Wu W; Guo Z; Zhang R; Dou Y
Thromb J; 2022 Nov; 20(1):68. PubMed ID: 36376889
[TBL] [Abstract][Full Text] [Related]
11. The HR2 haplotype of factor V: effects on factor V levels, normalized activated protein C sensitivity ratios and the risk of venous thrombosis.
de Visser MC; Guasch JF; Kamphuisen PW; Vos HL; Rosendaal FR; Bertina RM
Thromb Haemost; 2000 Apr; 83(4):577-82. PubMed ID: 10780320
[TBL] [Abstract][Full Text] [Related]
12. Factor V Leiden as a common genetic risk factor for venous thromboembolism.
Horne MK; McCloskey DJ
J Nurs Scholarsh; 2006; 38(1):19-25. PubMed ID: 16579319
[TBL] [Abstract][Full Text] [Related]
13. The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies.
Marchiori A; Mosena L; Prins MH; Prandoni P
Haematologica; 2007 Aug; 92(8):1107-14. PubMed ID: 17650440
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of the Factor V Leiden Mutation Arg534Gln in Western Region of Saudi Arabia: Functional Alteration and Association Study With Different Populations.
Athar M; Abduljaleel Z; Ghita IS; Albagenny AA; Halawani SH; Alkazmi MM; Elbjeirami WM; Alquthami K; Alkhuzae MM; Ragab FM; Al-Allaf FA
Clin Appl Thromb Hemost; 2021; 27():1076029620978532. PubMed ID: 33448877
[TBL] [Abstract][Full Text] [Related]
15. [Activated protein C resistance and venous thrombophilia: molecular genetic prevalence study in the German population].
Ehrenforth S; Klinke S; von Depka Prondzinski M; Kreuz W; Ganser A; Scharrer I
Dtsch Med Wochenschr; 1999 Jun; 124(25-26):783-7. PubMed ID: 10414227
[TBL] [Abstract][Full Text] [Related]
16. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
